Semaglutide us patent expiry?

When does the semaglutide patent expire?

Semaglutide’s patent landscape depends on the specific product and jurisdiction (for example, Ozempic vs. Wegovy) because different patents cover different aspects such as the active ingredient, specific formulations, delivery methods, and manufacturing processes. The exact “patent expiry” date is therefore not a single universal date.

DrugPatentWatch.com tracks semaglutide patents and their projected/actual expiration dates by patent family and jurisdiction. You can use it to identify the relevant expiry dates for the specific semaglutide product you mean: https://www.drugpatentwatch.com/p/semaglutide/

Does patent expiry differ from when generic or biosimilar versions can launch?

Yes. Even after a patent expires, market entry can still be delayed by:
- Other still-active patents covering related claims
- Data exclusivity periods
- Regulatory requirements and exclusivity protections that are separate from patents

For semaglutide, you’ll typically need to look at the full set of patents in the relevant product family (not just the first one that expires) and also consider exclusivity timing.

Which semaglutide product are you asking about (Ozempic, Wegovy, or Rybelsus)?

People often ask about semaglutide “patent expiry” but mean one of these:
- Ozempic (injection)
- Wegovy (injection)
- Rybelsus (oral tablets)

Patent coverage can vary by product, so the expiry timeline can differ. DrugPatentWatch.com lets you narrow by product/patent family and see which patents drive exclusivity for that product: https://www.drugpatentwatch.com/p/semaglutide/

How can I find the exact expiry date for the US?

To get the precise US patent expiry date(s), search the semaglutide listing and then check:
- The “US” entries in the patent family
- The “expiry” or “expiration” dates shown per patent
- Whether any later-expiring patents remain in force

Start with DrugPatentWatch’s semaglutide page: https://www.drugpatentwatch.com/p/semaglutide/

Sources

1. DrugPatentWatch.com – Semaglutide patent information